IND
Xtrackers Nifty 500 India ETF
$23.08
$-0.07 (-0.28%)
Delayed ≥20 min · Sep 1, 2026
Key Statistics
Net Assets (AUM)
$4.61M
Expense Ratio
See prospectus
Previous Close
$23.14
Day Range
- – -
52-Week Range
$20.52 – $27.40
Volume
424
Avg Vol (50D)
-
Beta
0.85
Historical Performance
1M
+0.85%
3M
+4.15%
6M
+1.20%
YTD
-7.07%
1Y
-8.13%
3Y
—
5Y
—
Total return including reinvested distributions, from adjusted closing prices.
Price History
Price history is being compiled for this fund.
Top Holdings
HDFCB HDFC Bank Ltd.
6.78%
ICICIBC ICICI Bank Ltd.
4.94%
RELIANC Reliance Industries Ltd.
4.65%
BHARTI Bharti Airtel Ltd.
2.61%
LT Larsen & Toubro Ltd.
2.54%
SBIN State Bank of India
2.47%
INFO Infosys Ltd.
2.27%
DWS GOVERNMENT MONEY MARKET SERIES INSTITUTIONAL SHARES
2.21%
AXSB Axis Bank Ltd.
1.99%
KMB Kotak Mahindra Bank Ltd.
1.53%
MM Mahindra & Mahindra Ltd.
1.52%
ITC ITC Ltd.
1.49%
TCS Tata Consultancy Services Ltd.
1.34%
BAF Bajaj Finance Ltd.
1.31%
HUVR Hindustan Unilever Ltd.
1.04%
MSIL Maruti Suzuki India Ltd.
0.97%
SUNP Sun Pharmaceutical Industries Ltd.
0.91%
NTPC NTPC Ltd.
0.90%
TTAN Titan Co Ltd.
0.89%
ETERNAL Eternal Ltd.
0.88%
TATA Tata Steel Ltd.
0.87%
BHE Bharat Electronics Ltd.
0.81%
SHFL Shriram Finance Ltd.
0.76%
UTCEM Ultratech Cement Ltd.
0.75%
HCLT HCL Technologies Ltd.
0.74%
Top 25 holdings as of Feb 28, 2026 · source: SEC N-PORT. Full holdings & prospectus →
About IND
DELISTED - No Description Available
IND News
- Scotiabank names veteran European banking executive Ralph Hamers to board
- Scotiabank welcomes Ralph Hamers to its Board of Directors
- Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program
- MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
- MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
- Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update
- Legal & General Group Plc Makes New $10.78 Million Investment in Voya Financial, Inc. $VOYA
- Progress on share buyback programme
- Why Did ING Group (NYSE:ING) See Short Interest Rise on NYSE?
- Persevere Therapeutics Announces Appointment of James Barlow to Board of Directors
- Great Southern drilling unlocks second growth front at WA gold play
- Man Group plc Purchases Shares of 60,305 Voya Financial, Inc. $VOYA
Data for IND is aggregated from third-party providers (Tiingo, Nasdaq, Finnhub) and SEC filings, may be delayed at least 20 minutes, and may be incomplete or contain errors. Nothing here is investment advice. Verify with the official prospectus before investing.